Toxoplasmosis in Cats: Fecal Shedding, Zoonotic Risk, and One Health Implications

Etiology and Life Cycle of Toxoplasma gondii in Felids

Toxoplasma gondii is an obligate intracellular apicomplexan parasite that uses felids, both domestic and wild, as definitive hosts [1, 2]. The parasite completes its sexual cycle exclusively within the feline intestinal epithelium, leading to the production of environmentally resistant oocysts that are shed in feces [1, 2]. Recent single-cell transcriptomic analyses have mapped the sexual development of T. gondii in the feline gut, revealing distinct transcriptional programs governing gametogenesis and oocyst wall formation [2]. Pre-sexual stages proliferate through a specialized cell division process characterized by endodyogeny and schizogony, a feature that distinguishes feline-specific development from asexual replication in intermediate hosts [1].

MicroRNA expression dynamics in the feline small intestine during T. gondii infection show that host-encoded microRNAs modulate the intestinal environment to favor parasite development [3]. The microneme protein MIC17A has been identified as a potential marker for both entero-epithelial and chronic stage infections in cats, facilitating detection of actively shedding individuals [4]. The AB blood group phenotype in cats does not influence susceptibility to T. gondii infection, suggesting that host genetic factors beyond blood group antigens determine individual risk [5].

Oocysts are shed in an unsporulated, non-infectious form and require 1-5 days of exposure to oxygen and moderate temperatures to sporulate and become infectious [6]. Sporulated oocysts can remain viable in soil, water, and on surfaces for months to years, contributing to environmental contamination and transmission to intermediate hosts [7, 8]. The life cycle is completed when a felid ingests tissue cysts from an infected intermediate host (e.g., rodents, birds) or sporulated oocysts from the environment [9, 10].

Epidemiology of Fecal Shedding and Seroprevalence

Fecal shedding of T. gondii oocysts by cats is the primary source of environmental contamination and zoonotic risk [6]. Studies using PCR detection of T. gondii DNA in fecal samples from stray cats in Bangkok, Thailand reported prevalence rates of 11.4% for oocyst shedding [6]. In Jordan, molecular detection of T. gondii DNA in cat feces yielded a prevalence of 8.7%, while seroprevalence was 36.4% [9]. In Hong Kong, seroprevalence in community cats was 16.1%, and in privately-owned cats 8.7%, with age and outdoor access identified as significant risk factors [11]. In Bangladesh, seroprevalence among cats in Trishal was 27.6%, with genotype distribution showing predominance of clonal type II [10].

Seroprevalence in domestic and companion animals from urban informal settlements in Salvador, Brazil reached 65.9% in cats, highlighting the role of environmental degradation and social marginalization in perpetuating T. gondii transmission [7, 8]. High seroprevalence rates have also been reported in dogs in the Pantanal region of Brazil (50.2%), reflecting widespread environmental contamination [12]. In livestock, T. gondii infection in dairy cattle in Turkey was 45.3% by ELISA, while goats in Nigeria showed 35.6% seroprevalence, with associations to water source and contact with cats [13, 14]. In Spain, pig farms with strict biosecurity had seroprevalence below 5%, demonstrating that management practices reduce exposure [15].

Reproductive tissues from companion animals in a neutering program in Brazil contained T. gondii DNA in 4.2% of samples, indicating potential vertical transmission [16]. In an aborted equine fetus in Brazil, molecular detection confirmed transplacental infection [17]. Similarly, T. gondii was detected in aborted fetal goat myocardium in Algeria, with histopathological lesions consistent with necrosis and inflammation [18]. Seroprevalence in deer in Iraq was 7.5%, suggesting wildlife as sentinels of environmental contamination [19].

Human seroprevalence data relevant to feline transmission include studies on pregnant women in Turkey (36.2% seropositive) and veterinary professionals in Mexico (39.5% seropositive), confirming occupational and domestic cat exposure as risk factors [20, 21, 22]. Women with a history of abortion or stillbirth in Turkey showed higher seropositivity (41.5%) compared to controls (27.1%), underscoring the reproductive consequences of exposure [20]. Sickle cell disease patients in Ghana had 42.7% seroprevalence, with transfusion history as an independent risk factor [23]. Cerebral toxoplasmosis in renal transplant recipients is a rare but severe complication of reactivation [24]. Childhood T. gondii exposure has been associated with psychotic experiences and reduced grey matter volume in a population-based cohort [25]. Ocular toxoplasmosis in adults requires multidisciplinary management [26]. Knowledge and practices regarding toxoplasmosis among pregnant women in Côte d'Ivoire were inadequate, indicating a need for public education [22]. University students in Iraq demonstrated moderate knowledge but poor awareness of cat litter box risks [27].

Clinical Signs and Pathology in Cats

Most cats infected with T. gondii remain asymptomatic [9, 5]. Clinical toxoplasmosis in cats primarily manifests in immunocompromised or young animals and can include lethargy, anorexia, fever, and pneumonia due to acute pulmonary infection [4]. Ocular signs such as anterior uveitis, chorioretinitis, and optic neuritis occur in a subset of cats [26]. Neurologic signs, including seizures, ataxia, and behavior changes, result from multifocal encephalomyelitis [28]. Hepatic and pancreatic involvement may cause icterus or vomiting.

Pathologically, the enteroepithelial cycle in the feline small intestine causes transient mucosal inflammation and desquamation of infected enterocytes [2, 3]. Systemic infection occurs when tachyzoites disseminate via the lymphatics and blood, leading to necrosis in the liver, lungs, lymph nodes, and brain. Tissue cysts (bradyzoites) form in skeletal muscle, myocardium, and neural tissues, persisting for life [16]. Vertical transmission in pregnant queens can result in abortion, stillbirth, or neonatal toxoplasmosis with neurological and ocular lesions [16].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis can be challenging due to intermittent fecal shedding and subclinical infections [6]. Serological detection of anti-T. gondii IgG and IgM antibodies using commercial ELISA kits is the most common method [9, 5]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed for detection of T. gondii antibodies in multiple host species, including cats, providing a rapid field-deployable alternative to ELISA [29]. Similarly, a SAG1-based colloidal gold strip has been validated for swine but can be adapted for feline use [30].

Molecular detection by PCR on fecal samples is sensitive for detecting oocyst shedding [6]. An antisense PCR assay has been developed specifically for T. gondii detection in domestic cats, targeting the B1 gene with improved sensitivity and specificity [31]. The MIC17A protein has utility as a serological marker for distinguishing entero-epithelial infection from chronic carriage [4]. Real-time PCR on aqueous humor can aid diagnosis of ocular toxoplasmosis in cats [26].

Table 1: Diagnostic methods for feline toxoplasmosis

Fecal flotation and microscopy are unreliable for oocyst detection due to low sensitivity and requirement for sporulation [6]. Histopathology of intestinal biopsies or tissues can reveal tachyzoites and cysts, but is rarely performed antemortem [18, 16].

The following Mermaid diagram illustrates a recommended diagnostic workflow for cats with suspected toxoplasmosis.

flowchart TD
    A[Cat with clinical signs or exposure history], > B{Serological test?}
    B, >|IgG positive, IgM negative| C[Chronic infection; no active shedding likely]
    B, >|IgM positive (any IgG)| D[Probable recent infection; test feces]
    D, > E{Fecal PCR for T. gondii}
    E, >|Positive| F[Active oocyst shedding; implement hygiene]
    E, >|Negative| G[Possible tissue phase only; repeat serology in 2-3 weeks]
    C, > H[No further action unless immunocompromised]
    F, > I[Quarantine, environmental decontamination]
    G, > J[Monitor clinical signs; consider treatment if progressive]

Treatment and Control

Treatment of feline toxoplasmosis is indicated in clinically ill cats or those with active ocular or neurological disease. Clindamycin (10-12 mg/kg orally twice daily for 2-4 weeks) is the drug of choice. Alternative regimens include sulfadiazine-trimethoprim or pyrimethamine combined with sulfonamides. No licensed vaccine for cats is available; however, gene-edited live-attenuated vaccines have shown promise in experimental models by deletion of virulence genes, leading to protective immunity without oocyst shedding [32]. Recent advances in mRNA vaccine design and One Health strategies aim to develop vaccines that block transmission in both cats and intermediate hosts [33].

Control of shedding relies on reducing exposure of cats to infected prey and raw meat. Feeding commercially cooked food and keeping cats indoors mitigates the risk of ingesting tissue cysts [34]. Daily removal of feces from litter boxes prevents sporulation of oocysts; litter boxes should be cleaned with boiling water or steam to inactivate oocysts. Immunocompromised individuals should delegate litter box duties or wear gloves and mask [34, 28]. Environmental decontamination is challenging because oocysts resist most disinfectants; only ammonia (>10%) or heat (>55°C for 10 minutes) reliably kills sporulated oocysts.

One Health Implications

Toxoplasma gondii exemplifies the One Health concept because its transmission links the health of cats, other animals, humans, and the environment [33]. Cats serve as the definitive host and primary source of environmental oocyst contamination [7, 8]. Oocysts from cat feces contaminate soil, water, and food crops, leading to infection in livestock and wildlife and subsequently to human foodborne illness [14, 13, 10]. Zoonotic risk is highest for pregnant women (risk of congenital toxoplasmosis) and immunocompromised individuals (risk of encephalitis, pneumonia) [20, 22, 24, 34]. Ocular toxoplasmosis can cause vision loss in immunocompetent individuals [26]. Personality changes and neuropsychiatric associations, including increased risk-taking behavior, have been attributed to latent T. gondii infection, likely via manipulation of host behavior to enhance transmission to cats [28]. Social marginalization and environmental degradation in urban informal settlements exacerbate exposure risk by increasing contact with stray cats and contaminated soil [7, 35, 8].

A unified One Health approach requires collaboration between veterinarians, physicians, ecologists, and public health officials to implement surveillance, vaccination (when available), and education campaigns. Reducing cat overpopulation through neutering programs and responsible ownership reduces environmental contamination [16]. Educational interventions for pregnant women and cat owners improve knowledge and practices, as demonstrated in Abidjan and Erbil [22, 27]. Field-validated rapid diagnostic strips enable community-based screening [29, 30]. The development of antisense PCR assays and molecular epidemiological tools supports precise monitoring of circulating genotypes and transmission dynamics [31, 10].

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[4] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[5] Spada E, Tattarletti G, Proverbio D et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41471183/

[6] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[7] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[8] Bazan L, Argibay HD, Borges-Silva W et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41401226/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[9] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[10] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/

[11] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[12] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[13] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[14] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[15] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[16] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[17] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[18] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[19] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[20] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[21] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[22] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[23] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[24] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[25] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[26] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[27] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[28] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. https://pubmed.ncbi.nlm.nih.gov/41481062/

[29] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[30] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[31] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[32] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[33] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[34] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[35] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/